Pratik Narain Srivastava Selected Research

narirutin

2/2022

Dietary flavonoid narirutin as a prospective antagonist of oncogenic pri/pre-microRNAs.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pratik Narain Srivastava Research Topics

Disease

5	Malaria 10/2022 - 01/2018
2	Infections 01/2020 - 08/2019
1	Neoplasms (Cancer) 02/2022
1	Rupture 01/2022

Drug/Important Bio-Agent (IBA)

1	EnzymesIBA 10/2022
1	MannosyltransferasesIBA 10/2022
1	3' Untranslated Regions (3' UTR)IBA 02/2022
1	MicroRNAs (MicroRNA)IBA 02/2022
1	PhytochemicalsIBA 02/2022
1	FlavonoidsIBA 02/2022
1	Messenger RNA (mRNA)IBA 02/2022
1	narirutinIBA 02/2022
1	Phospholipases A2 (Phospholipase A2)IBA 01/2022
1	DNA (Deoxyribonucleic Acid)IBA 01/2021
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	ThrombospondinsIBA 01/2020
1	Protein Kinases (Protein Kinase)IBA 08/2019
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 08/2019
1	shikimateIBA 01/2018

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 01/2018